Income Statement
PROKIDNEY CORP.
PROK
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
165.90 | 183.75 | 151.52 | 153.01 | 0.00 |
|
Research & Development
|
114.12 | 127.67 | 106.71 | 82.07 | - |
|
Selling, General & Administrative
|
51.78 | 56.08 | 44.82 | 70.94 | - |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-165.90 | -183.75 | -151.52 | -153.01 | - |
|
Non-Operating Income
|
-14.70 | -19.82 | -22.07 | -5.77 | - |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
0.00 | 0.01 | 0.01 | 0.22 | - |
|
Other Non-Op Income / Expense
|
- | - | - | - | - |
|
Income Before Tax
|
-151.20 | -163.93 | -129.45 | -147.24 | - |
|
Income Tax Expense
|
-82.21 | -102.75 | -93.98 | 0.90 | - |
|
Non-Controlling Interest
|
-151.61 | -163.34 | - | - | - |
|
Net Income
|
-68.99 | -61.19 | -35.47 | -148.14 | - |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-159.33 | -178.32 | -147.67 | -149.97 | 0.00 |
|
Earnings Per Share (Basic)
|
-0.52 | -0.62 | -0.57 | -0.23 | - |
|
Diluted EPS
|
-0.52 | -0.62 | -0.57 | -0.23 | - |
|
Weighted Average Shares
|
133.94 | 97.92 | 61.71 | 61.54 | - |
|
Diluted Weighted Avg Shares
|
133.94 | 97.92 | 61.71 | 61.54 | - |
|
Comprehensive Income
|
-69.06 | -61.19 | -35.34 | -108.03 | - |